The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

 

Search Results

NCRI Cancer Conference 2009: A new dawn – Monoclonal antibodies

800px-antibody_igg2There are so many different types of cancer drugs coming into the clinic that it can sometimes be hard to keep up.  Among the most exciting additions in the last decade are monoclonal antibodies (mAbs)  – Herceptin and rituximab are two examples.

 

No Comments | Trackback | Permalink

 

ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 For Treatment of Small Cell Lung Cancer

 

No Comments | Trackback | Permalink

 

Lung cancer: Molecular scissors determine therapy effectiveness

 

No Comments | Trackback | Permalink

 

ImmunoCellular Therapeutics Granted Patents Covering Its Lead Monoclonal Antibody Cancer Product Candidate

 

No Comments | Trackback | Permalink

 

Data to Be Presented At ESMO 2008 Highlight Pfizer Commitment to Cancer Care and Research

 

No Comments | Trackback | Permalink

 

Target-seeking Antibodies For Cancer Therapy

 

No Comments | Trackback | Permalink

 

Compugen Announces Discovery of Novel Drug Targets for Cancer Antibody Therapeutics

 

No Comments | Trackback | Permalink

 

Experimental Drug Makes the Immune System Revolt Against Cancer

 

No Comments | Trackback | Permalink

 

Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study

 

No Comments | Trackback | Permalink

 

Getting up close and personal

 

No Comments | Trackback | Permalink